201–250 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
201	FGF2	fibroblast growth factor 2	4	Clinical TrialsHighly Studied	879
202	PSEN1	presenilin 1	14	ProteaseFDA Approved Target	879
203	PIK3R1	phosphoinositide-3-kinase regulatory subunit 1	5	TransporterClinical Trials	878
204	FN1	fibronectin 1	2	FDA Approved TargetOMIM Disease Gene	875
205	HBB	hemoglobin subunit beta	11	TransporterFDA Approved Target	874
206	SLC6A3	solute carrier family 6 member 3	5	TransporterOMIM Disease Gene	869
207	TRAF6	TNF receptor associated factor 6	11	Highly StudiedTrending	868
208	PRNP	prion protein (Kanno blood group)	20	OMIM Disease GeneHighly Studied	867
209	MBL2	mannose binding lectin 2	10	Highly StudiedExperimental GO Evidence	863
210	GJB2	gap junction protein beta 2	13	OMIM Disease GeneHighly Studied	860
211	RAD51	RAD51 recombinase	15	DNA RepairHomologous Recombination	860
212	COL1A1	collagen type I alpha 1 chain	17	Highly ConstrainedFDA Approved Target	858
213	AURKA	aurora kinase A	20	KinaseOncogene	855
214	TCF7L2	transcription factor 7 like 2	10	Transcription FactorOMIM Disease Gene	854
215	VCP	valosin containing protein	9	DNA RepairHighly Constrained	852
216	ABCA1	ATP binding cassette subfamily A member 1	9	TransporterFDA Approved Target	851
217	PKM	pyruvate kinase M1/2	15	KinaseHighly Studied	850
218	NOS2	nitric oxide synthase 2	17	Clinical TrialsHighly Studied	843
219	HLA-DQA1	major histocompatibility complex, class II, DQ alpha 1	6	Highly StudiedExperimental GO Evidence	838
220	ALK	ALK receptor tyrosine kinase	2	KinaseOncogene	836
221	HGF	hepatocyte growth factor	7	Clinical TrialsOMIM Disease Gene	835
222	TNFRSF1A	TNF receptor superfamily member 1A	12	ReceptorEarly Pipeline	834
223	CYP19A1	cytochrome P450 family 19 subfamily A member 1	15	FDA Approved TargetOMIM Disease Gene	833
224	FLT3	fms related receptor tyrosine kinase 3	13	KinaseOncogene	833
225	HSPA1A	heat shock protein family A (Hsp70) member 1A	6	Highly StudiedExperimental GO Evidence	833
226	FLT1	fms related receptor tyrosine kinase 1	13	KinaseReceptor	832
227	ALDH2	aldehyde dehydrogenase 2 family member	12	FDA Approved TargetOMIM Disease Gene	829
228	HRAS	HRas proto-oncogene, GTPase	11	OncogeneOMIM Disease Gene	829
229	TLR9	toll like receptor 9	3	ReceptorFDA Approved Target	827
230	CD14	CD14 molecule	5	Clinical TrialsHighly Studied	824
231	HDAC2	histone deacetylase 2	6	FDA Approved TargetHighly Studied	824
232	CCL5	C-C motif chemokine ligand 5	17	Highly StudiedExperimental GO Evidence	821
233	FOXO1	forkhead box O1	13	ApoptosisHighly Constrained	821
234	CDC42	cell division cycle 42	1	OMIM Disease GeneHighly Studied	820
235	MCL1	MCL1 apoptosis regulator, BCL2 family member	1	Clinical TrialsHighly Studied	820
236	SOX2	SRY-box transcription factor 2	3	Highly ConstrainedTranscription Factor	818
237	HSPB1	heat shock protein family B (small) member 1	7	Clinical TrialsOMIM Disease Gene	817
238	PPARGC1A	PPARG coactivator 1 alpha	4	Highly StudiedExperimental GO Evidence	807
239	FOXO3	forkhead box O3	6	Highly ConstrainedOncogene	805
240	AHR	aryl hydrocarbon receptor	7	ReceptorTranscription Factor	804
241	TNFRSF11B	TNF receptor superfamily member 11b	8	ReceptorOMIM Disease Gene	804
242	ANXA2	annexin A2	15	Highly StudiedTrending	801
243	ELAVL1	ELAV like RNA binding protein 1	19	Highly ConstrainedHighly Studied	800
244	MGMT	O-6-methylguanine-DNA methyltransferase	10	DNA RepairHighly Studied	800
245	YWHAZ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta	8	Highly ConstrainedOMIM Disease Gene	798
246	EGF	epidermal growth factor	4	OMIM Disease GeneHighly Studied	797
247	ACTB	actin beta	7	Highly ConstrainedOMIM Disease Gene	796
248	SLC2A1	solute carrier family 2 member 1	1	Highly ConstrainedTransporter	796
249	HTT	huntingtin	4	Clinical TrialsOMIM Disease Gene	794
250	PGR	progesterone receptor	11	ReceptorFDA Approved Target	793